Global Biotechnology Media, Sera and Reagents Market Likely to Reach $32.98 Billion by 2025, Says Allied Market Research Print E-mail
By GLOBE NEWSWIRE   
Thursday, 14 March 2019 04:03

Porland,OR,, March 14, 2019 (GLOBE NEWSWIRE)

Porland,OR,, March 14, 2019 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report, titled, Biotechnology Media, Sera and Reagents Market by Type (Media, Sera and Reagent), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, and Others), and End User (Biotechnology & Pharmaceutical Companies, Academic Institute, Research Laboratory): Global Opportunity Analysis and Industry Forecast, 2018–2025”. According to the report, the global biotechnology media, sera, and reagents market accounted for $18.79 billion in 2017 and is projected to reach $32.98 billion by 2025, registering a CAGR of 7.3% during the period from 2018 to 2025.

The market is segmented on the basis of type, application, end user, and geography. Based on type, the market is divided into media, sera, and reagent. The media segment is projected to manifest the fastest CAGR of 8.1% during the forecast period. However, the reagents segment held the largest share in 2017, contributing nearly three-fourths of the total market.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5176

On the basis of application, the market is segmented into cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, and others. The cancer research segment held the largest share in 2017, contributing nearly one-third of the total revenue. However, the biopharmaceuticals segment is expected to register the fastest CAGR of 8.2% during the forecast period.

Based on end user, the market is divided into biotechnology & pharmaceutical companies, academic institute, and research laboratory. The biotechnology and pharmaceutical companies segment is expected to lucrative opportunities as it is estimated to register the fastest CAGR of 8% through 2025 and held the largest share in 2017, contributing nearly half of the market. Geographically, the report is bifurcated into North America, Asia-Pacific, LAMEA, and Europe.

The report includes the major market players in the industry such as GE Healthcare, Merck KGaA (Sigma Aldrich), HiMedia Laboratories Pvt., Ltd, Merck & Co., Inc., Corning Incorporated, Bio-Rad Laboratories Inc., Sartorius AG, Lonza Group Ltd, Thermofisher Scientific, Becton, and Dickinson and Company.

Read More at: https://www.alliedmarketresearch.com/press-release/biotechnology-media-sera-and-reagents-market.html

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:  David Correa  5933 NE Win Sivers Drive  #205, Portland, OR 97220  United States  USA/Canada (Toll Free):   +1-800-792-5285, +1-503-894-6022, +1-503-446-1141  UK: +44-845-528-1300  Hong Kong: +852-301-84916  India (Pune): +91-20-66346060  Fax: +1(855)550-5975  [email protected]   Web: https://www.alliedmarketresearch.com

Primary Logo




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter